Global Dermatomyositis Treatment Supply, Demand and Key Producers, 2023-2029

March 2023 | 110 pages | ID: G4FC2A947796EN
GlobalInfoResearch

Abstracts

The global Dermatomyositis Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Dermatomyositis is a rare inflammatory skin disorders that is typically characterized by muscle weakness and a severe skin rash. It is mainly caused by either viral infection of the tissues of skeletal muscle or autoimmune reaction. Symptoms may vary broadly from patient to patient. Deformities in the muscles may initiate with weakness and pain in the muscles of the thighs, the hips, the upper arms, and the trunk. The muscles may become sore, tender, and stiff and eventually express signs of degeneration.

This report studies the global Dermatomyositis Treatment production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Dermatomyositis Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dermatomyositis Treatment that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Dermatomyositis Treatment total production and demand, 2018-2029, (K Units)

Global Dermatomyositis Treatment total production value, 2018-2029, (USD Million)

Global Dermatomyositis Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Dermatomyositis Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Dermatomyositis Treatment domestic production, consumption, key domestic manufacturers and share

Global Dermatomyositis Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Dermatomyositis Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Dermatomyositis Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Dermatomyositis Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Endo International Inc, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Cipla Inc, Dr Reddy's Laboratories Ltd, Abbott, F. Hoffmann -La Roche Ltd and Pfizer Inc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dermatomyositis Treatment market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Dermatomyositis Treatment Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Dermatomyositis Treatment Market, Segmentation by Type

• Immunosuppressants
• Glucocorticoids

Global Dermatomyositis Treatment Market, Segmentation by Application

• Hospital
• Specialty Clinic
• Other

Companies Profiled:

• Novartis AG
• Endo International Inc
• Teva Pharmaceutical Industries Ltd
• Glenmark Pharmaceuticals Ltd
• Cipla Inc
• Dr Reddy's Laboratories Ltd
• Abbott
• F. Hoffmann -La Roche Ltd
• Pfizer Inc
• Zydus Group
• Lupin
• Amorphex Therapeutics Holdings, Inc
• Bausch Health Companies Inc

Key Questions Answered

1. How big is the global Dermatomyositis Treatment market?

2. What is the demand of the global Dermatomyositis Treatment market?

3. What is the year over year growth of the global Dermatomyositis Treatment market?

4. What is the production and production value of the global Dermatomyositis Treatment market?

5. Who are the key producers in the global Dermatomyositis Treatment market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Dermatomyositis Treatment Introduction
1.2 World Dermatomyositis Treatment Supply & Forecast
  1.2.1 World Dermatomyositis Treatment Production Value (2018 & 2022 & 2029)
  1.2.2 World Dermatomyositis Treatment Production (2018-2029)
  1.2.3 World Dermatomyositis Treatment Pricing Trends (2018-2029)
1.3 World Dermatomyositis Treatment Production by Region (Based on Production Site)
  1.3.1 World Dermatomyositis Treatment Production Value by Region (2018-2029)
  1.3.2 World Dermatomyositis Treatment Production by Region (2018-2029)
  1.3.3 World Dermatomyositis Treatment Average Price by Region (2018-2029)
  1.3.4 North America Dermatomyositis Treatment Production (2018-2029)
  1.3.5 Europe Dermatomyositis Treatment Production (2018-2029)
  1.3.6 China Dermatomyositis Treatment Production (2018-2029)
  1.3.7 Japan Dermatomyositis Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Dermatomyositis Treatment Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Dermatomyositis Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Dermatomyositis Treatment Demand (2018-2029)
2.2 World Dermatomyositis Treatment Consumption by Region
  2.2.1 World Dermatomyositis Treatment Consumption by Region (2018-2023)
  2.2.2 World Dermatomyositis Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Dermatomyositis Treatment Consumption (2018-2029)
2.4 China Dermatomyositis Treatment Consumption (2018-2029)
2.5 Europe Dermatomyositis Treatment Consumption (2018-2029)
2.6 Japan Dermatomyositis Treatment Consumption (2018-2029)
2.7 South Korea Dermatomyositis Treatment Consumption (2018-2029)
2.8 ASEAN Dermatomyositis Treatment Consumption (2018-2029)
2.9 India Dermatomyositis Treatment Consumption (2018-2029)

3 WORLD DERMATOMYOSITIS TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Dermatomyositis Treatment Production Value by Manufacturer (2018-2023)
3.2 World Dermatomyositis Treatment Production by Manufacturer (2018-2023)
3.3 World Dermatomyositis Treatment Average Price by Manufacturer (2018-2023)
3.4 Dermatomyositis Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Dermatomyositis Treatment Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Dermatomyositis Treatment in 2022
  3.5.3 Global Concentration Ratios (CR8) for Dermatomyositis Treatment in 2022
3.6 Dermatomyositis Treatment Market: Overall Company Footprint Analysis
  3.6.1 Dermatomyositis Treatment Market: Region Footprint
  3.6.2 Dermatomyositis Treatment Market: Company Product Type Footprint
  3.6.3 Dermatomyositis Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Dermatomyositis Treatment Production Value Comparison
  4.1.1 United States VS China: Dermatomyositis Treatment Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: Dermatomyositis Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Dermatomyositis Treatment Production Comparison
  4.2.1 United States VS China: Dermatomyositis Treatment Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Dermatomyositis Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Dermatomyositis Treatment Consumption Comparison
  4.3.1 United States VS China: Dermatomyositis Treatment Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: Dermatomyositis Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Dermatomyositis Treatment Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based Dermatomyositis Treatment Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Dermatomyositis Treatment Production Value (2018-2023)
  4.4.3 United States Based Manufacturers Dermatomyositis Treatment Production (2018-2023)
4.5 China Based Dermatomyositis Treatment Manufacturers and Market Share
  4.5.1 China Based Dermatomyositis Treatment Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Dermatomyositis Treatment Production Value (2018-2023)
  4.5.3 China Based Manufacturers Dermatomyositis Treatment Production (2018-2023)
4.6 Rest of World Based Dermatomyositis Treatment Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based Dermatomyositis Treatment Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Dermatomyositis Treatment Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers Dermatomyositis Treatment Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Dermatomyositis Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Immunosuppressants
  5.2.2 Glucocorticoids
5.3 Market Segment by Type
  5.3.1 World Dermatomyositis Treatment Production by Type (2018-2029)
  5.3.2 World Dermatomyositis Treatment Production Value by Type (2018-2029)
  5.3.3 World Dermatomyositis Treatment Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Dermatomyositis Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Specialty Clinic
  6.2.3 Other
6.3 Market Segment by Application
  6.3.1 World Dermatomyositis Treatment Production by Application (2018-2029)
  6.3.2 World Dermatomyositis Treatment Production Value by Application (2018-2029)
  6.3.3 World Dermatomyositis Treatment Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 Novartis AG
  7.1.1 Novartis AG Details
  7.1.2 Novartis AG Major Business
  7.1.3 Novartis AG Dermatomyositis Treatment Product and Services
  7.1.4 Novartis AG Dermatomyositis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 Novartis AG Recent Developments/Updates
  7.1.6 Novartis AG Competitive Strengths & Weaknesses
7.2 Endo International Inc
  7.2.1 Endo International Inc Details
  7.2.2 Endo International Inc Major Business
  7.2.3 Endo International Inc Dermatomyositis Treatment Product and Services
  7.2.4 Endo International Inc Dermatomyositis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Endo International Inc Recent Developments/Updates
  7.2.6 Endo International Inc Competitive Strengths & Weaknesses
7.3 Teva Pharmaceutical Industries Ltd
  7.3.1 Teva Pharmaceutical Industries Ltd Details
  7.3.2 Teva Pharmaceutical Industries Ltd Major Business
  7.3.3 Teva Pharmaceutical Industries Ltd Dermatomyositis Treatment Product and Services
  7.3.4 Teva Pharmaceutical Industries Ltd Dermatomyositis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
  7.3.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.4 Glenmark Pharmaceuticals Ltd
  7.4.1 Glenmark Pharmaceuticals Ltd Details
  7.4.2 Glenmark Pharmaceuticals Ltd Major Business
  7.4.3 Glenmark Pharmaceuticals Ltd Dermatomyositis Treatment Product and Services
  7.4.4 Glenmark Pharmaceuticals Ltd Dermatomyositis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Glenmark Pharmaceuticals Ltd Recent Developments/Updates
  7.4.6 Glenmark Pharmaceuticals Ltd Competitive Strengths & Weaknesses
7.5 Cipla Inc
  7.5.1 Cipla Inc Details
  7.5.2 Cipla Inc Major Business
  7.5.3 Cipla Inc Dermatomyositis Treatment Product and Services
  7.5.4 Cipla Inc Dermatomyositis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Cipla Inc Recent Developments/Updates
  7.5.6 Cipla Inc Competitive Strengths & Weaknesses
7.6 Dr Reddy's Laboratories Ltd
  7.6.1 Dr Reddy's Laboratories Ltd Details
  7.6.2 Dr Reddy's Laboratories Ltd Major Business
  7.6.3 Dr Reddy's Laboratories Ltd Dermatomyositis Treatment Product and Services
  7.6.4 Dr Reddy's Laboratories Ltd Dermatomyositis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Dr Reddy's Laboratories Ltd Recent Developments/Updates
  7.6.6 Dr Reddy's Laboratories Ltd Competitive Strengths & Weaknesses
7.7 Abbott
  7.7.1 Abbott Details
  7.7.2 Abbott Major Business
  7.7.3 Abbott Dermatomyositis Treatment Product and Services
  7.7.4 Abbott Dermatomyositis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 Abbott Recent Developments/Updates
  7.7.6 Abbott Competitive Strengths & Weaknesses
7.8 F. Hoffmann -La Roche Ltd
  7.8.1 F. Hoffmann -La Roche Ltd Details
  7.8.2 F. Hoffmann -La Roche Ltd Major Business
  7.8.3 F. Hoffmann -La Roche Ltd Dermatomyositis Treatment Product and Services
  7.8.4 F. Hoffmann -La Roche Ltd Dermatomyositis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 F. Hoffmann -La Roche Ltd Recent Developments/Updates
  7.8.6 F. Hoffmann -La Roche Ltd Competitive Strengths & Weaknesses
7.9 Pfizer Inc
  7.9.1 Pfizer Inc Details
  7.9.2 Pfizer Inc Major Business
  7.9.3 Pfizer Inc Dermatomyositis Treatment Product and Services
  7.9.4 Pfizer Inc Dermatomyositis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 Pfizer Inc Recent Developments/Updates
  7.9.6 Pfizer Inc Competitive Strengths & Weaknesses
7.10 Zydus Group
  7.10.1 Zydus Group Details
  7.10.2 Zydus Group Major Business
  7.10.3 Zydus Group Dermatomyositis Treatment Product and Services
  7.10.4 Zydus Group Dermatomyositis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 Zydus Group Recent Developments/Updates
  7.10.6 Zydus Group Competitive Strengths & Weaknesses
7.11 Lupin
  7.11.1 Lupin Details
  7.11.2 Lupin Major Business
  7.11.3 Lupin Dermatomyositis Treatment Product and Services
  7.11.4 Lupin Dermatomyositis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.11.5 Lupin Recent Developments/Updates
  7.11.6 Lupin Competitive Strengths & Weaknesses
7.12 Amorphex Therapeutics Holdings, Inc
  7.12.1 Amorphex Therapeutics Holdings, Inc Details
  7.12.2 Amorphex Therapeutics Holdings, Inc Major Business
  7.12.3 Amorphex Therapeutics Holdings, Inc Dermatomyositis Treatment Product and Services
  7.12.4 Amorphex Therapeutics Holdings, Inc Dermatomyositis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.12.5 Amorphex Therapeutics Holdings, Inc Recent Developments/Updates
  7.12.6 Amorphex Therapeutics Holdings, Inc Competitive Strengths & Weaknesses
7.13 Bausch Health Companies Inc
  7.13.1 Bausch Health Companies Inc Details
  7.13.2 Bausch Health Companies Inc Major Business
  7.13.3 Bausch Health Companies Inc Dermatomyositis Treatment Product and Services
  7.13.4 Bausch Health Companies Inc Dermatomyositis Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.13.5 Bausch Health Companies Inc Recent Developments/Updates
  7.13.6 Bausch Health Companies Inc Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Dermatomyositis Treatment Industry Chain
8.2 Dermatomyositis Treatment Upstream Analysis
  8.2.1 Dermatomyositis Treatment Core Raw Materials
  8.2.2 Main Manufacturers of Dermatomyositis Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Dermatomyositis Treatment Production Mode
8.6 Dermatomyositis Treatment Procurement Model
8.7 Dermatomyositis Treatment Industry Sales Model and Sales Channels
  8.7.1 Dermatomyositis Treatment Sales Model
  8.7.2 Dermatomyositis Treatment Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Dermatomyositis Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Dermatomyositis Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Dermatomyositis Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Dermatomyositis Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Dermatomyositis Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Dermatomyositis Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Dermatomyositis Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Dermatomyositis Treatment Production Market Share by Region (2018-2023)
Table 9. World Dermatomyositis Treatment Production Market Share by Region (2024-2029)
Table 10. World Dermatomyositis Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Dermatomyositis Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Dermatomyositis Treatment Major Market Trends
Table 13. World Dermatomyositis Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Dermatomyositis Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Dermatomyositis Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Dermatomyositis Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Dermatomyositis Treatment Producers in 2022
Table 18. World Dermatomyositis Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Dermatomyositis Treatment Producers in 2022
Table 20. World Dermatomyositis Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Dermatomyositis Treatment Company Evaluation Quadrant
Table 22. World Dermatomyositis Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Dermatomyositis Treatment Production Site of Key Manufacturer
Table 24. Dermatomyositis Treatment Market: Company Product Type Footprint
Table 25. Dermatomyositis Treatment Market: Company Product Application Footprint
Table 26. Dermatomyositis Treatment Competitive Factors
Table 27. Dermatomyositis Treatment New Entrant and Capacity Expansion Plans
Table 28. Dermatomyositis Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Dermatomyositis Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Dermatomyositis Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Dermatomyositis Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Dermatomyositis Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Dermatomyositis Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Dermatomyositis Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Dermatomyositis Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Dermatomyositis Treatment Production Market Share (2018-2023)
Table 37. China Based Dermatomyositis Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Dermatomyositis Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Dermatomyositis Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Dermatomyositis Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Dermatomyositis Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Dermatomyositis Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Dermatomyositis Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Dermatomyositis Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Dermatomyositis Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Dermatomyositis Treatment Production Market Share (2018-2023)
Table 47. World Dermatomyositis Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Dermatomyositis Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Dermatomyositis Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Dermatomyositis Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Dermatomyositis Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Dermatomyositis Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Dermatomyositis Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Dermatomyositis Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Dermatomyositis Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Dermatomyositis Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Dermatomyositis Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Dermatomyositis Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Dermatomyositis Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Dermatomyositis Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 62. Novartis AG Major Business
Table 63. Novartis AG Dermatomyositis Treatment Product and Services
Table 64. Novartis AG Dermatomyositis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis AG Recent Developments/Updates
Table 66. Novartis AG Competitive Strengths & Weaknesses
Table 67. Endo International Inc Basic Information, Manufacturing Base and Competitors
Table 68. Endo International Inc Major Business
Table 69. Endo International Inc Dermatomyositis Treatment Product and Services
Table 70. Endo International Inc Dermatomyositis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Endo International Inc Recent Developments/Updates
Table 72. Endo International Inc Competitive Strengths & Weaknesses
Table 73. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Teva Pharmaceutical Industries Ltd Major Business
Table 75. Teva Pharmaceutical Industries Ltd Dermatomyositis Treatment Product and Services
Table 76. Teva Pharmaceutical Industries Ltd Dermatomyositis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 78. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 79. Glenmark Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Glenmark Pharmaceuticals Ltd Major Business
Table 81. Glenmark Pharmaceuticals Ltd Dermatomyositis Treatment Product and Services
Table 82. Glenmark Pharmaceuticals Ltd Dermatomyositis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Glenmark Pharmaceuticals Ltd Recent Developments/Updates
Table 84. Glenmark Pharmaceuticals Ltd Competitive Strengths & Weaknesses
Table 85. Cipla Inc Basic Information, Manufacturing Base and Competitors
Table 86. Cipla Inc Major Business
Table 87. Cipla Inc Dermatomyositis Treatment Product and Services
Table 88. Cipla Inc Dermatomyositis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Cipla Inc Recent Developments/Updates
Table 90. Cipla Inc Competitive Strengths & Weaknesses
Table 91. Dr Reddy's Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Dr Reddy's Laboratories Ltd Major Business
Table 93. Dr Reddy's Laboratories Ltd Dermatomyositis Treatment Product and Services
Table 94. Dr Reddy's Laboratories Ltd Dermatomyositis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Dr Reddy's Laboratories Ltd Recent Developments/Updates
Table 96. Dr Reddy's Laboratories Ltd Competitive Strengths & Weaknesses
Table 97. Abbott Basic Information, Manufacturing Base and Competitors
Table 98. Abbott Major Business
Table 99. Abbott Dermatomyositis Treatment Product and Services
Table 100. Abbott Dermatomyositis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Abbott Recent Developments/Updates
Table 102. Abbott Competitive Strengths & Weaknesses
Table 103. F. Hoffmann -La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 104. F. Hoffmann -La Roche Ltd Major Business
Table 105. F. Hoffmann -La Roche Ltd Dermatomyositis Treatment Product and Services
Table 106. F. Hoffmann -La Roche Ltd Dermatomyositis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. F. Hoffmann -La Roche Ltd Recent Developments/Updates
Table 108. F. Hoffmann -La Roche Ltd Competitive Strengths & Weaknesses
Table 109. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 110. Pfizer Inc Major Business
Table 111. Pfizer Inc Dermatomyositis Treatment Product and Services
Table 112. Pfizer Inc Dermatomyositis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Pfizer Inc Recent Developments/Updates
Table 114. Pfizer Inc Competitive Strengths & Weaknesses
Table 115. Zydus Group Basic Information, Manufacturing Base and Competitors
Table 116. Zydus Group Major Business
Table 117. Zydus Group Dermatomyositis Treatment Product and Services
Table 118. Zydus Group Dermatomyositis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Zydus Group Recent Developments/Updates
Table 120. Zydus Group Competitive Strengths & Weaknesses
Table 121. Lupin Basic Information, Manufacturing Base and Competitors
Table 122. Lupin Major Business
Table 123. Lupin Dermatomyositis Treatment Product and Services
Table 124. Lupin Dermatomyositis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Lupin Recent Developments/Updates
Table 126. Lupin Competitive Strengths & Weaknesses
Table 127. Amorphex Therapeutics Holdings, Inc Basic Information, Manufacturing Base and Competitors
Table 128. Amorphex Therapeutics Holdings, Inc Major Business
Table 129. Amorphex Therapeutics Holdings, Inc Dermatomyositis Treatment Product and Services
Table 130. Amorphex Therapeutics Holdings, Inc Dermatomyositis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Amorphex Therapeutics Holdings, Inc Recent Developments/Updates
Table 132. Bausch Health Companies Inc Basic Information, Manufacturing Base and Competitors
Table 133. Bausch Health Companies Inc Major Business
Table 134. Bausch Health Companies Inc Dermatomyositis Treatment Product and Services
Table 135. Bausch Health Companies Inc Dermatomyositis Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Dermatomyositis Treatment Upstream (Raw Materials)
Table 137. Dermatomyositis Treatment Typical Customers
Table 138. Dermatomyositis Treatment Typical Distributors

List Of Figures

LIST OF FIGURES

Figure 1. Dermatomyositis Treatment Picture
Figure 2. World Dermatomyositis Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Dermatomyositis Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Dermatomyositis Treatment Production (2018-2029) & (K Units)
Figure 5. World Dermatomyositis Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Dermatomyositis Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Dermatomyositis Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Dermatomyositis Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Dermatomyositis Treatment Production (2018-2029) & (K Units)
Figure 10. China Dermatomyositis Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Dermatomyositis Treatment Production (2018-2029) & (K Units)
Figure 12. Dermatomyositis Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Dermatomyositis Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Dermatomyositis Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Dermatomyositis Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Dermatomyositis Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Dermatomyositis Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Dermatomyositis Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Dermatomyositis Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Dermatomyositis Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Dermatomyositis Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Dermatomyositis Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Dermatomyositis Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Dermatomyositis Treatment Markets in 2022
Figure 26. United States VS China: Dermatomyositis Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Dermatomyositis Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Dermatomyositis Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Dermatomyositis Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Dermatomyositis Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Dermatomyositis Treatment Production Market Share 2022
Figure 32. World Dermatomyositis Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Dermatomyositis Treatment Production Value Market Share by Type in 2022
Figure 34. Immunosuppressants
Figure 35. Glucocorticoids
Figure 36. World Dermatomyositis Treatment Production Market Share by Type (2018-2029)
Figure 37. World Dermatomyositis Treatment Production Value Market Share by Type (2018-2029)
Figure 38. World Dermatomyositis Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Dermatomyositis Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Dermatomyositis Treatment Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Specialty Clinic
Figure 43. Other
Figure 44. World Dermatomyositis Treatment Production Market Share by Application (2018-2029)
Figure 45. World Dermatomyositis Treatment Production Value Market Share by Application (2018-2029)
Figure 46. World Dermatomyositis Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Dermatomyositis Treatment Industry Chain
Figure 48. Dermatomyositis Treatment Procurement Model
Figure 49. Dermatomyositis Treatment Sales Model
Figure 50. Dermatomyositis Treatment Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source